Back to top
more

Alcon (ALC)

(Delayed Data from NYSE)

$73.37 USD

73.37
690,704

-0.33 (-0.45%)

Updated Aug 25, 2026 03:54 PM ET

After-Market: $73.37 0.00 (0.00%) 5:48 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (149 out of 246)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Company News for May 15, 2025

by Zacks Equity Research

Companies in The News Are: ARCO,DT,EXEL,ALC

Zacks Equity Research

Alcon Q1 Earnings Miss Estimates, Stock Down, 2025 EPS View Lowered

by Zacks Equity Research

ALC ends the first quarter of 2025 on a disappointing note.

Zacks Equity Research

Alcon (ALC) Reports Q1 Earnings: What Key Metrics Have to Say

by Zacks Equity Research

The headline numbers for Alcon (ALC) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Mark Vickery headshot

Top Research Reports for Texas Instruments, Boeing & NextEra Energy

by Mark Vickery

Today's Research Daily features new research reports on 16 major stocks, including Texas Instruments Incorporated (TXN), The Boeing Company (BA) and NextEra Energy, Inc. (NEE).

Zacks Equity Research

Ahead of Alcon (ALC) Q1 Earnings: Get Ready With Wall Street Estimates for Key Metrics

by Zacks Equity Research

Evaluate the expected performance of Alcon (ALC) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

Zacks Equity Research

Do Options Traders Know Something About Alcon Stock We Don't?

by Zacks Equity Research

Investors need to pay close attention to ALC stock based on the movements in the options market lately.

Zacks Equity Research

ALC Stock May Rise With the Introduction of PanOptix Pro in US

by Zacks Equity Research

Alcon introduces Clareon PanOptix Pro IOL to select practices across the United States, with commercial availability expected in May.

Zacks Equity Research

The Zacks Analyst Blog Highlights Alcon, Glaukos and Regeneron Pharmaceuticals

by Zacks Equity Research

Alcon, Glaukos and Regeneron Pharmaceuticals are part of the Zacks top Analyst Blog.

Urmimala Biswas headshot

3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy Space

by Urmimala Biswas

ALC, GKOS and REGN are well-positioned to benefit from the evolving space of cell-based ophthalmic therapy.

Zacks Equity Research

Avanos Medical (AVNS) Down 5.8% Since Last Earnings Report: Can It Rebound?

by Zacks Equity Research

Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.